Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Duration of Protection by Antihistaminics in Anaphylactic Shock

Abstract

Traina and Aleksandrowicz reported recently1 that, in contrast to the findings of Pasteur, Vallery-Radot, Halpern and Holtzer2, guinea pigs which survived a previous exposure to anaphylactic shock during antihistaminic treatment were protected against a second challenging injection of the sensitizing agent given one day later. These experiments were carried out on thirteen guinea pigs, of which two were used for control. The implication of such a result might become extremely broad from the point of view of the mechanism of action of antihistaminic drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

CHESSIN, M., ERCOLI, N. Duration of Protection by Antihistaminics in Anaphylactic Shock. Nature 164, 957 (1949). https://doi.org/10.1038/164957a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/164957a0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing